+36.1%
MRNA vs BLDR
-57.1%
+93.2%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BLDR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.4% | +3.0% | +4.1% |
| 7D | -1.1% | -8.2% | +7.2% | +3.5% |
| 30D | +126.1% | -16.6% | +142.7% | +151.1% |
| 3M | +190.0% | -23.2% | +213.2% | +227.3% |
| 6M | +157.2% | -33.7% | +191.0% | +203.7% |
| YTD | +388.2% | -41.3% | +429.5% | +494.7% |
| 1Y | +467.0% | -58.8% | +525.8% | +685.3% |
| 3Y | +36.1% | -57.5% | +93.5% | +67.2% |
| All | +36.1% | -57.1% | +93.2% | +67.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BLDR.
Daily Out/Under-Performance
Portfolio return minus BLDR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BLDR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BLDR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling